Leyla Ozer
- Specialization: Surgical oncologist
- 12 years of experience
- Speaks:English
- Workplace: Turkey, Istanbul, Memorial Bahçelievler Hospital
- Member of the Turkish Medical Oncology Association; former Head of the Medical Oncology Department at Fırat University Hospital.
Dr. Leyla Ozer is a medical oncologist at Memorial Bahçelievler Hospital in Istanbul. She focuses on chemotherapy, immunotherapy, and targeted therapy for cancer. Her clinical expertise includes treating gastrointestinal cancers and rare tumor types. Dr. Ozer completed her medical oncology specialization at Istanbul University.
- Served as the Head of the Medical Oncology Department at Fırat University Hospital.
- Member of the Turkish Medical Oncology Association.
- Published clinical research on breast, pancreatic, and hematologic cancers.
- Works at a LEED Platinum-certified hospital, the first of its kind in Turkey.
Patient reviews
How are we doing?
Qualifications
Oncology Specialization
Dr. Ozer designs individualized treatment plans using evidence-based chemotherapy and modern systemic therapies. She achieves outcomes for patients with gastrointestinal and rare tumors. The specialist also treats breast cancer, pancreatic cancer, and hematologic malignancies. Her approach integrates immunotherapy and targeted therapy to address specific cancer cell characteristics.
Work Experience
- Present – Medical Oncologist, Memorial Bahçelievler Hospital, Istanbul
- 2015 – Medical Oncologist, Acıbadem Health Group
- 2014–2015 – Head of the Medical Oncology Department, Fırat University Hospital
Education and Training
- 2013 – Medical Oncology specialization, Istanbul University Istanbul Faculty of Medicine
- 2008 – Internal Medicine specialization, Istanbul University Istanbul Faculty of Medicine
- 2001 – Medical Degree, Istanbul University Cerrahpaşa Faculty of Medicine
Research and Publications
Dr. Ozer has co-authored numerous peer-reviewed articles in national and international journals. Her research investigates prognostic factors in metastatic pancreatic cancer. She also studies triple-negative breast cancer outcomes and thyroid cancer. This work includes studies on hyponatremia – a condition where sodium levels in the blood are abnormally low – in oncology patients.
- "Prognostic factors in metastatic pancreatic cancer"
- "Triple-negative breast cancer outcomes"
- "Hyponatremia in oncology patients"
Professional Memberships
- Turkish Medical Oncology Association (Türk Tıbbi Onkoloji Derneği)
You may also be interested
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.